FortuneDisease Agnostic: Using AI to Pivot and Combat COVID-19Jul 09, 2020Media CoverageRelated contentTempus Expands Strategic Collaboration with Bristol Myers SquibbTempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLCTempus to Report Third Quarter 2026 Financial Results on November 2